Dr. Michael Y. Chan, MD

Dr. Chan practices at Providence St. Joseph Hospital Orange in Orange, California, part of Providence Health & Services.

Dr. Chan's NPI, 1487660833, was assigned on July 31, 2006. Dr. Chan graduated from Stanford University School Of Medicine in 1997. Dr. Chan holds California license A73775.

Dr. Chan's primary practice is Providence St. Joseph Hospital Orange, at 1100 West Stewart Dr, Orange, CA 92868 in Orange County. The practice phone is (714) 633-9111.

Dr. Chan's primary practice is Providence St. Joseph Hospital Orange in Orange, California, part of Providence Health & Services. Dr. Chan is also affiliated with Providence St. Jude Medical Center. The medical group on file is St. Jude Heritage Medical Group. Dmand AI also links Dr. Chan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chan practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Chan is board certified in interventional cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Chan's licenses on file in 3 states: California, Texas and Maryland.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension and chronic skin ulcer among the conditions Dr. Chan treats.

CMS data shows 752 Medicare services from Dr. Chan across 19 procedure codes in 2024, for 343 Medicare patients. Medicare paid $69,377 for them.

CMS counts 343 Medicare patients who saw Dr. Chan in 2024. The largest group is 75 to 84, with 152 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chan's median patient age at 72, with 50% women.

In 2024, Dr. Chan wrote 1,879 Medicare Part D claims for 336 patients. 85% of them were for generic drugs. CMS names the drug for 1,705 of them, across 33 drugs with 11 or more claims each, at $256,994 in total drug cost. In 2023, CMS named 1,999 claims across 36 drugs.

Dr. Chan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chan as offering telehealth. CMS counts 49 procedures of coronary angioplasty and stenting by Dr. Chan, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Chan in 2008. The most frequent topics are Angioplasty, Balloon, Coronary and Cardiac Catheterization. Dr. Chan's most frequent co-author is Andrew John Boyle, MD.

Dmand AI links Dr. Chan to 1 clinical trial. Conditions studied include Postphlebitic Syndrome and Phlebitis.

CMS Open Payments shows 1,089 general payments to Dr. Chan from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. AstraZeneca Pharmaceuticals LP paid the most, $157,027.

Dmand AI lists 2 awards for Dr. Chan, most recently ACC Fellow in 2012.

Dr. Chan graduated from Stanford University School Of Medicine in 1997. Dr. Chan is a member of ACC.

Dr. Chan is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.